No Data
Express News | Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $23
New Analyst Forecast: $FLGT Given 'Outperform' Rating
Piper Sandler Reaffirms Their Hold Rating on Fulgent Genetics (FLGT)
Raymond James Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Announces Target Price $25
Fulgent Genetics Analyst Ratings
Great Week for Fulgent Genetics, Inc. (NASDAQ:FLGT) Institutional Investors After Losing 4.4% Over the Previous Year
Coach Donnie : Let’s GOOO